Morphine Market Size, Share, Growth, Research and Forecast 2020-2026
A full report of Global Morphine Market is available at: https://www.omrglobal.com/industry-reports/morphine-market
In November 2018, the Food and Drug Administration (FDA) approved the R&D of morphine drug to develop new opioid painkiller. One of the novel product is Dsuvia is one of the morphine drug used by medical professionals under restricted regulations that are prescribed for emergency cases, in surgical operations by hospitals. Dsuvia dosage only prescribed when the patient is incapable to swallow the medicine. Sun Pharmaceutical Industries Ltd., Vertice Pharma LLC, Purdue Pharma LP, Rhodes Technologies LP, Teva Pharmaceutical, Mallinckrodt LLC, Allergan Plc, Hikma Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Egalet Corp., and so on are the key players operating in the global morphine market.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/morphine-market
These players are actively engaged in making new product launches which in turn is driving the growth of the global morphine market. For instance, in August 2019, Upsher-Smith Laboratories, LLC had launched Morphine Sulfate Tablets, CII, 15, and 30 mg. According to the IQVIA, the morphine sulfate tablet market had US sales of approximately $49 million for the 12 months ending June 2019. In March 2019, Piramal Critical Care had launched Morphine Sulfate injection with Mitigo trademark in the US. The launched morphine sulfate injection is used for the treatment of intractable chronic pain. The injection has been launched in 10 mg/ml and 25 mg/ml concentrations. The company had launched this injection to diversify its presence in the field of anesthesia, pain management, and intrathecal therapy.
In January 2017, Lupin, Ltd. had launched its US FDA approval for morphine sulfate ER tablet (in strengthening 15 mg, 30 mg, 60 mg, 100 mg, and 200 mg). Morphine sulfate ER tablet is indicated for the management of pain severe enough to require daily, timely, long-term opioid treatment and for which the use of the alternative treatment options are inadequate.
Global Morphine Market Segmentation
• Oral Tablets
• Cough Suppressant
• Diarrhea Suppressant
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/morphine-market
Global Morphine Market – Segment by Region
• United States
• United Kingdom
• Rest of Europe
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
• Allergan PLC
• Alcaliber S.A.
• Daiichi Sankyo, Inc.
• Macfarian Smith, Ltd. (A Part of Johnson Matthey PLC’s Fine Chemicals Division)
• Mallinckrodt PLC
• Manus Aktteva Biopharma LLP
• Mylan N.V.
• Mayne Pharma Group, Ltd.
• Pfizer, Inc.
• Purdue Pharma LP
• Sanofi S.A.
• Sun Pharmaceuticals Industries, Ltd.
• Taj Pharmaceuticals, Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries, Ltd.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Morphine Market Size, Share, Growth, Research and Forecast 2020-2026 here
News-ID: 2079764 • Views: 271
More Releases from Orion Market Research
India Specialty Chemicals Market Size, Industry Share, Growth & Forecast To 2020 …
India specialty chemical market is anticipated to grow at a considerable CAGR of 9.5%. The rising utility of agrochemicals in the country to meet the growing needs for sustainable crop production is a key factor contributing towards the growth of India's specialty chemical market. India is an agriculture-based country with approximately 75% of the population is reliant on farming, directly or indirectly. India has witnessed significant demand for agrochemicals owing
European Specialty Chemicals Market Size, Trends, Competitive Analysis, Share, F …
European specialty chemicals market is anticipated to exhibit a CAGR of 3.7% during the forecast period. The growing use of specialty chemicals in the end-user industries is a key factor driving the European specialty chemical market. In the automobile industry, specialty chemicals are mainly used to perform specialty coating on the vehicles. As per the European Chemical Industry Council (CEFIC), the specialty chemical held the major share of more than
China Specialty Chemicals Market Size, Share, Trends and Forecast To 2020-2026
China's specialty chemical market is anticipated to grow at a considerable CAGR of 5.1%. The availability of low-cost raw material, cheap labor, favorable government regulation for the manufacturing of specialty chemicals in the region. High production volume leads to low manufacturing costs and volume sales of chemicals in the country. China is the key supplier of different specialty chemicals used in the formation of finished products such as plastic, fertilizers,
Global Specialty Chemicals Market Size, Industry Share, Growth & Forecast To 202 …
The specialty chemicals market is anticipated to exhibit a CAGR of 4.9% during the forecast period. The growing use of specialty chemicals in the end-user industries is a key factor driving the global specialty chemical market. Cement manufacturing, concrete production, corrosion inhibition, coating, and paints are the key applications of specialty chemicals in the construction industry. In cement production, specialty chemicals are used as a combustion agent, fuels, gypsum, and
More Releases for Pharma
Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business